Welch & Forbes’s Insulet PODD Stock Holding History

Welch & Forbes’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,500	Closed	-$639K	–	393
2020 Q4	$639K	Buy	+2,500	New	+$620K	0.01%	249

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Welch & Forbes's PODD Position: Q1 2021 in Review

Welch & Forbes sold out of Insulet (PODD) in Q1 2021, closing a stake of 2,500 shares — an estimated $639K sold.

Welch & Forbes first reported a position in PODD in Q4 2020 and held it in 1 quarter. The position peaked at $639K in Q4 2020. 452 funds tracked by Wall St. Rank hold PODD as of Q1 2021.

Welch & Forbes reported no remaining Insulet position as of Q1 2021 after selling out during the quarter.
Welch & Forbes sold 2,500 Insulet shares in Q1 2021, an estimated $639K.
Welch & Forbes first reported a position in Insulet in Q4 2020 and held it in 1 quarter.
Welch & Forbes's Insulet position peaked at $639K in Q4 2020.
452 funds tracked by Wall St. Rank held Insulet as of Q1 2021.

Based on Welch & Forbes's 13F filing for Q1 2021, filed 14 Apr 2021.